HNHacker News
TopNewBestAskShowJobs

seehafer

1,143 karma · joined November 22, 2008

Software engineer turned medical device product manager turned SaaS CEO. Now exited and trying to be a voice for little tech at the FDA.
submissionscomments
seehafer··on Theranos Is Subject of Criminal Probe by U.S
> If you want to "hack" healthcare and fix the problem, get involved in government and get single payer done.

So we can turn what health technology gets developed into even more of a political game? Building a board of government insiders as opposed to scientists and clinical experts is exactly the kind of move that would work especially well in a single payer system. You want to know what healthcare would look like when governments were the only payors worldwide? Look at defense contracting. Or aerospace. He who had the best lobbyist would win.

If I could change one thing about the commenting on the state of our health care system it would be to require everyone who says "oh we just need single payer" to spend a year working for an insurer, a hospital, and a health technology manufacturer. Then come tell me that changing who pays will fix all problems. Here is a following not-comprehensive list of things that would not be fixed just be going to single payer:

- the US subsidizing all health tech (drug/device) development

- fee-for-service payment structure leading to perverse incentives

- malpractice fears leading to risk-averse, defensive medicine

- poor reimbursement rates yielding waiting lists to be seen by a doctor

- bureaucrats in CMS (the payors) exerting influence on the FDA to not approve new technology because they feel it is too similar to existing technology

- regulators creating vague rules that get applied differently from case to case, making them impossible to plan for

I could go on. I do agree with you that a lot of startups in the space are putting a bandaid on a bleeding jugular. But saying "let's get government more involved" neglects the fact that we're in this problem in part because government is very involved and has been since WWII.

There are three ways you can make healthcare better and cheaper for everyone:

- Make health technology cheaper

- Change the way health care is paid for (I credit Oscar for trying to make it in this space but for various reasons think they're unlikely to succeed)

- Change the way that health care is delivered

There are a number of startups tackling the latter (telemedicine, doctors on demand, drugs delivered to you, etc). Unfortunately the Affordable Care Act has many provisions that make it difficult to innovate in this space, because of the view that it's much easier to control costs when the point-of-care is controlled by a few big hospital systems.

I run a startup that's trying to tackle my first solution: making health tech cheaper by making it easier for startups to get their products through regulators and disrupt incumbents.

But even if we're wildly successful and can start lowering health tech costs across the board, the problem won't be fixed until we fix the payment structure, which will require innovation in payment models, not a one-size-fits-all government plan.

seehafer··on Theranos Is Subject of Criminal Probe by U.S
When I first read this headline I was thinking "Uh oh, Theranos must have very badly handled its interactions with FDA". But this is apparently the SEC investigating the company.

Does anyone know how often the SEC investigates a private company with a product that's still essentially in beta testing?

seehafer··on A New Map for America
Yes, that's most certainly true, but that's b/c not so much because of native water (the Rockies trap a lot), but b/c CO sold much of its water to AZ and CA long ago.
seehafer··on A New Map for America
Umm... Except for la veta pass Interstate 25 runs east of the Rockies from Denver to Albuquerue. More possible than you think.

Denver to SLC, on the other hand, you'd be 100% correct about.

seehafer··on Theranos Ran Tests Despite Quality Problems
>At what point here do people go to jail?

Generally the FDA will give companies several outs to fix problems, they only bring out the handcuffs after several ratcheting steps (one of which includes bringing in a US Marshal and a team from the FDA, at your expense, to be at your business every day and tell you how to run your company).

seehafer··on Theranos Ran Tests Despite Quality Problems
Arizona.
seehafer··on China's Subprime Crisis Is Here
> but how else can you characterize voting, multiple times, to not only shut down the whole government but actually trying to make it default on its debt?

A last ditch effort to try to bring some sanity to a budgeting process so broken that the the national debt has doubled since Obama became President.

seehafer··on Google Bets on Health
Some folks on the inside think Google has an ambition to replace the insurance companies.

http://medcitynews.com/2016/01/google-biogen-payer-cms/

seehafer··on Google Bets on Health
> Between insurance companies, doctors, hospitals, patients, governments, and every middleman inbetween

You can eliminate middlemen if you can show cost reductions for a player larger than the middleman. The big players are providers, payors and technology (pharma/device) companies. Plenty of middlemen in between those that can be made irrelevant.

seehafer··on GitHub is undergoing a full-blown overhaul as execs and employees depart
Scary that you're getting downvoted for this comment.
seehafer··on GitHub is undergoing a full-blown overhaul as execs and employees depart
> It blows my mind that some people really believe that only white people can be racist. It's like they completely redefined the meaning of the word "racist".

That's the point. Redefine words so that it's impossible for someone who doesn't share their point of view to have any moral high ground.

seehafer··on U.S. Probes Theranos Complaints
Thank you for pointing this out. You'd be surprised how many people even within medical device think design control necessarily means some slow-as-hell waterfall development method.
seehafer··on U.S. Probes Theranos Complaints
Not necessarily to the former. Definitely to the latter.

To elaborate point 1:

- If the crucial parts of the devices that "were modified to improve accuracy" were modified early on in the study the data could be representative of the final product.

- The same applies for the devices not being fully assembled. If they weren't fully assembled, and the data were still good enough to defend a 510k, then the data should represent worst case usage, unless full assembly would somehow make the technology less performant.

seehafer··on How Theranos Misled Me
http://www.fiercebiotech.com/story/roche-wins-fda-approval-n...
seehafer··on U.S. Probes Theranos Complaints
What's notable about the meat of the complaint sent to the FDA is that it's less "this technology actually doesn't work" and more "this company has no culture of experimental integrity".

From the article:

"hadn’t fully assembled the proprietary machines used for the herpes study when the experiments began" ... "company underreported the rate at which the machines broke down during the study" ... "employee also alleged that some crucial parts of the devices ... were modified to improve their accuracy"

FDA is generally skeptical of validation data not generated from "production equivalent" technology, but they get even more skeptical if you tell them something is X and it turns out to be Y down the road. That (rightly) sends them on a fishing expedition.

seehafer··on U.S. Probes Theranos Complaints
Falsifying data to obtain regulatory approval is definitely illegal, and federal regulations allow the government to hold corporate officers personally liable.

It has yet to be proven that Theranos did in fact falsify data, though.

seehafer··on Theranos Founder Faces a Test of Technology, and Reputation
For current public companies, you're right, because public company CEOs outside of recent tech cos are rarely founders.

Healthcare founders almost always have either medical and/or science training.

seehafer··on Obama Signs CISA Bill into Law
"They never lobby for (or introduce, if they're in a position to do so) bills to actually achieve that end, and in fact usually do nothing and let the status quo -- which until very recently was "keep the discriminatory laws on the books" -- stand."

How many self-professed libertarians are there in the Congress? Paul's not even self-professed libertarian. The only one I know is Justin Amash, and he couldn't introduce any of type of bills you reference because under Boehner's regime only bills blessed by his team could ever make it to the floor.

seehafer··on Can Theranos CEO Elizabeth Holmes Fend Off Her Critics?
It's not a bad theory, but even the military medical establishment would demand that the tests are accurate.
seehafer··on Not Even Twitter Understands Twitter
> It's rare to see anyone favoriting a tweet to "reference" it later.

A lot of broad statements being thrown around by both the author of this article and the people in this thread. I used favorites in exactly this way, and I'm not a marketer.

seehafer··on New Star Trek Series Premieres January 2017
One addition in terms of how Trek becomes great, from a behind-the-camera perspective:

7. Results from a tension between competing visions between writers and creators. Examples: TNG was campy and unwatchable, mostly, until Michael Piller took over as head writer in the third season and started focusing on characters and more traditional drama. Piller had an inclination to be too soap opera-y but was held in check by Roddenberry's presence and later, spirit. DS9 was the result of the tension between Ira Steven Behr and Berman aided by Ronald D Moore, and worked well until it became the all-war-all-the-time series. Voyager is the result of Berman, Braga and Jeri Taylor running wild without any counteracting force. Enterprise is the same (minus Taylor).

seehafer··on New Star Trek Series Premieres January 2017
Your wish is unlikely to come true, as the new series is being written/produced by the head writer of the last two movies.
seehafer··on The FDA's notes from its visit to Theranos' labs don't look good
Certainly the pivot-constantly, push-code-daily mentality is not translatable to medical technology. That said, biotech & device companies could stand to be a hell of a lot more agile. Compliance is necessary but it isn't a complete impediment to moving quickly.
seehafer··on The FDA's notes from its visit to Theranos' labs don't look good
I disagree. Device/diagnostic companies get 483's all the time. What's telling is the scope of these observations. Theranos is failing on most counts of the quality system regulations. Judging by the observations they don't even have a corrective action (CAPA) process. That's a huge red flag.
seehafer··on The FDA's notes from its visit to Theranos' labs don't look good
The FDA quality system regulations seem like nitpicking on their face, and they can be implemented in such a way that is very pedantic, but at their core this is really about an engineering process that is controlled and validated, which isn't, you know, unreasonable if you're talking about products that directly impact people's health.

Document numbers and release dates go toward ensuring everyone at the company is working with the same information. Most computer science students learn about the failure of the Mars Climate Orbiter [1] because one team was using feet and the other meters. Guarding against issues like those is exactly what FDA is trying to do.

1: http://articles.latimes.com/1999/oct/01/news/mn-17288

seehafer··on Theranos Dials Back Lab Tests at FDA’s Behest
> Starting with the Reagan administration, oversight over medical devices has been greatly reduced. You have a lot of leeway with medical devices, even moreso than with drugs.

Citation needed.

seehafer··on Theranos Dials Back Lab Tests at FDA’s Behest
>but you don't fuck around with the FDA

As 23andMe found out the hard way.

seehafer··on Theranos Dials Back Lab Tests at FDA’s Behest
As OopsCriticality points out above, it's incredibly difficult to judge the potential of Theranos' technology because they have so far refused to perform and/or publish peer-reviewed randomized clinical data comparing themselves to the standard of care.

I can add some nuance to the WSJ article as a veteran of medical devices and FDA inspections:

The WSJ article quotes the inspection as a "surprise". There are only two reasons this inspection should have been a surprise to Theranos. Either in their conversations with FDA they appeared to be less-than-forthcoming, or if they were not familiar with how the FDA operated. Pre-approval inspections (i.e. you submit an application to FDA and before they make a judgment they do an inspection of your site) are very common for new technology and in some cases mandatory. When exactly they show up you don't know, but you plan for them to show up, and you expect it within a certain window of time.

Theranos CEO Elizabeth Holmes has been vocal about the FDA exercising oversight over all "lab developed tests", i.e. novel testing methods developed by a laboratory for use only by that laboratory and not for sale to others. Currently, these tests are not regulated by FDA, but FDA's sister organization the Centers for Medicare and Medicaid Services (CMS), under a set of regulations called CLIA. CLIA regs are not as stringent as FDA oversight and are more about good laboratory practices as opposed to the safety and efficacy of any new technology. So, Theranos and Holmes are trying to hold themselves to a higher standard, which is admirable.

The caveat with doing that is that you should be familiar with what that standard is going to be. I am suspicious that we're getting the full story from the Journal article, because I find it bizarre that no one at Theranos thought that FDA would consider their "nanotainers" a medical device: when FDA gets involved, anything that is part of a diagnostic system gets their oversight. Someone with 3 months experience in medical device regulatory could have told Theranos this.

seehafer··on Jack Dorsey giving up 30% of his stake in Square to help underserved communities
The number is closer to 33% as long term capital gains are taxed as income in California.
seehafer··on Neural technologies could become the next battleground
Hahaha, I take it by your first line you have some neural engineering background?
← PreviousPage 6 of 10Next →